ENERGIZE-T
Sponsor
AGIOS
Description
Adult Thalassaemia study.
(AGIOS 018) CCTU - Phase 3, Double-blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Mitapivat in Subjects with Alpha- or Beta-Thalassaemia
Site name
Site name Pending
Site PI
Site PI Pending
Start date
Start Date Pending
End date
End Date Pending
